Leading European Universities Choose Elekta to Deliver Advanced 3D Brain Mapping Tool for Research
Posted on: Monday, 22 December 2008, 08:00 CST
MEG is a powerful tool for studying normal brain function and brain disorders. Elekta Neuromag is the world's most advanced and most used MEG system, providing real-time mapping of brain activity by non-invasively measuring the magnetic fields produced by the brain. Electrical activity in neurons in the brain produce magnetic fields that pass through brain tissue and the skull, which can then be recorded outside the head using Elekta Neuromag.
The first whole-head MEG in
"We are extremely excited about our upcoming installation," says Professor
Dedicated to brain and cognitive neuroscience research, a large group of researchers at the University of Trento's Center of Mind/Brain Sciences (CIMeC) plan to use Elekta Neuromag to explore various fields of neuroscience such as sensory processing, attention and action control, language, formation of concepts and cognitive development.
The University of Trento has recruited physicians from
"The addition of Elekta Neuromag will complement already established methods such as 4T functional magnetic resonance tomography (fMRT), transcranial magnetic stimulation (TMS) as well as multi-channel EEG - thus contributing to the advancement of our understanding of the brain," says Dr. Braun.
The University's MEG-lab is situated in the Italian countryside. "Not only is our MEG-lab optimally located for brain activity measurement, but patients also have an opportunity to enjoy a beautiful view of the Alps," continues Braun.
"The acquisition of Elekta Neuromag by two prominent European Universities
is a major opportunity for Elekta to work with
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution from the Elekta
Group. Elekta employs around 2,500 employees globally. The corporate
headquarter is located in
SOURCE Elekta
Source: PR Newswire
Related Articles
- Curcumin May Inhibit Nicotine-Induced Activation Of Head And Neck Cancers
- Military Brain Injury Rehab Program Returns More Than 70% of Patients to Full-Time, Active Duty Status in First Year
- Graduates of University of Miami Online High School Headed to Top Universities Around the Country
- Study Uses Light to Control Brain Activity
- Reata Brain Cancer Therapy Shows Strong Activity
- Goosen and Els head field for Scottish Open
- University of Georgia Budget Director to Head Up Finance and Administration
- Federer, Nadal, Safin head field for Paris-Bercy Masters
- CORRECTED- Federer, Nadal head field for Paris-Bercy Masters
- University of Iowa; New activity discovered in cystic fibrosis protein
User Comments (0)

RSS Feeds